Compare Enzyme (MLN) vs ZeroLend (ZERO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs ZeroLend — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while ZeroLend trades at Rp0.1389 (market cap Rp9,92M, Rp2,19M 24h volume). The key difference: Enzyme is far larger — about 13.5× ZeroLend's market cap, and ZeroLend's supply is capped (54,9B / 100B ZERO (55%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and ZeroLend for 27 Days on average.
| MLN | ZERO | |
|---|---|---|
Market Cap | Rp134,13M | Rp9,92M |
Volume (24h) | Rp104,56M | Rp2,19M |
Circulating Supply | 3,3M MLN | 54,9B / 100B ZERO (55%) |
Typical Hold Time | 28 Days | 27 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently shows a market cap of Rp134,13M with 3,3jt tokens in circulation. The asset demonstrates moderate holding patterns with an average hold time of 28 days. Trading activity appears limited given the relatively small market capitalization. Recent market data suggests the token is operating in a niche segment of the cryptocurrency ecosystem with specific utility focused on decentralized finance protocols.
Overall outlook remains cautious due to limited liquidity and market depth. Key opportunities include potential ecosystem growth in DeFi sector, while major risks involve high volatility typical of small-cap cryptocurrencies and regulatory uncertainty affecting the broader crypto market. Investors should monitor on-chain activity and exchange listings for improved liquidity.
ZeroLend shows limited market activity with a modest market cap of Rp9,92M and 55% circulating supply. The token exhibits minimal trading volume and network engagement, with average hold time of 27 days suggesting cautious investor behavior. No recent protocol upgrades or ecosystem developments have been observed, indicating stagnant project momentum in the current market environment.
Outlook remains neutral with low liquidity posing challenges. Key opportunity lies in potential future protocol development, while major risks include extreme volatility due to thin order books and lack of sustained developer activity. Investors should monitor for renewed ecosystem engagement.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About ZeroLend
ZeroLend is a decentralized lending platform that transforms the digital asset lending and borrowing landscape. It operates on multiple chains, including zkSync and Manta Network, utilizing Layer 2 protocols to improve scalability and efficiency. The platform's native governance and utility token, ZERO, is essential to the ecosystem, allowing users to engage in governance and staking activities.
Read more on ZERO →
